IPMCL-28b

• Description:

  IPMCL-28b is an antibacterial agent targeting the bacterial cell membrane. Its minimum inhibitory concentration (MIC) against Staphylococcus aureus ATCC 25923 is 1.56 μg/mL, and the MIC against methicillin-resistant Staphylococcus aureus (MRSA) is 6.25 μg/mL. IPMCL-28b is expected to be used in the research of the anti-infection field[1].

• UNSPSC:

  12352005

• Target:

  Bacterial

• Related Pathways:

  Anti-infection

• Field of Research:

  Infection

• Smiles:

  O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCN(C(C5=CC=C(C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(NCCCCCCCCC)=O)=O)=O)=O)C=C5)=O)CC4)=C3)C1=O)O

• Molecular Formula:

  C52H77FN12O8

• Molecular Weight:

  1017.24

• References & Citations:

  [1]Wen Q, et al. Naturally inspired chimeric quinolone derivatives to reverse bacterial drug resistance. Eur J Med Chem. 2025 May 5;289:117496.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported